News

Verve Therapeutics (VERV) stock surged as promising trial data for cholesterol therapy VERVE-102 prompted Cantor Fitzgerald ...
Consistent in their evaluation, an analyst from Scotiabank keeps a Sector Outperform rating on AST SpaceMobile with a target price of $47. * In a cautious move, an analyst from Cantor Fitzgerald ...
Cantor Fitzgerald analysts initiated coverage of crypto exchange Coinbase (COIN) with an "Overweight" rating and price target ...
Cantor Fitzgerald lowered the firm’s price target on Amazon.com (AMZN) to $230 from $270 and keeps an Overweight rating on the shares. The Q1 ...
While acknowledging that the stock is prone to volatility, Cantor Fitzgerald, and others, see AST SpaceMobile as a great way for investors to gain exposure to the burgeoning private satellite ...
Cantor Fitzgerald views Bob Duggan’s, Summit Therapeutics (SMMT) co-CEO and Chairman, stock option exercise “quite unusual” and “quite bullish” for the shares. Duggan’ exercised ...
Cantor Fitzgerald doubled down on its bearish stance toward stocks on Monday, reaffirming its negative outlook with the statement, “we continue to be bearish on equities.” ...
(Bloomberg) -- Stock analysts at Cantor Fitzgerald, the firm long led by now-Commerce Secretary Howard Lutnick, upgraded their rating on Tesla Inc., the carmaker run by White House adviser Elon Musk.
Delving into the details, we found 18% of traders were bullish, while 63% showed bearish tendencies. Out of all the trades we spotted, 2 were puts, with a value of $82,942, and 9 were calls, valued at ...